Published in J Immunol on January 01, 1966
Congenital infections with reovirus. J Exp Med (1966) 0.89
Virus myocardiopathy. Prog Med Virol (1973) 2.73
Residual pathologic changes following murine coxsackie A and B myocarditis. Am J Pathol (1969) 2.47
Concentrations of acetoacetate and 3-hydroxybutyrate in pigeon blood and desert locust haemolymph. Life Sci II (1971) 2.01
Current problems in the treatment of infective endocarditis due to Pseudomonas aeruginosa. Rev Infect Dis (1983) 1.80
Characteristics of pneumonias caused by Escherichia coli. N Engl J Med (1967) 1.68
Incubation of swab materials with herpes simplex virus. J Infect Dis (1980) 1.58
Coxsackievirus myocarditis--with special reference to acute and chronic effects. Prog Cardiovasc Dis (1985) 1.57
Augmentation of the virulence of murine coxsackie-virus B-3 myocardiopathy by exercise. J Exp Med (1970) 1.54
Simultaneous serum and CSF antibodies in herpes simplex virus encephalitis. JAMA (1978) 1.48
The clinical spectrum of Mycoplasma pneumoniae infections. Med Clin North Am (1978) 1.46
Editorial response: microbial persistence and idiopathic dilated cardiomyopathy. Clin Infect Dis (1999) 1.45
Characteristics of nonbacteremic Pseudomonas pneumonia. Ann Intern Med (1968) 1.27
Bacteroides pneumonias. Characteristics of cases with empyema. Ann Intern Med (1968) 1.26
Differential sensitivity of herpes simplex virus types 1 and 2 to human interferon: antiviral effects of interferon plus 9-beta-D-arabinofuranosyladenine. J Infect Dis (1976) 1.21
Comparison of the activity of antibiotic combinations in vitro with clinical outcome and resistance emergence in serious infection by Pseudomonas aeruginosa in non-neutropenic patients. J Antimicrob Chemother (1987) 1.20
Herpesvirus hominis encephalitis in Michigan. Report of thirteen cases, including six treated with idoxuridine. N Engl J Med (1970) 1.18
Pneumonias caused by gram negative bacilli. Medicine (Baltimore) (1966) 1.18
Sociocultural factors and health care-seeking behavior among black Americans. J Natl Med Assoc (1987) 1.18
Coxsackievirus myocardiopathy. J Infect Dis (1969) 1.17
Passive hemagglutinating antibodies in cerebrospinal fluids in herpesvirus hominis encephalitis. 1. Proc Soc Exp Biol Med (1972) 1.16
Xeroradiographic, bacteriologic, and pathologic studies in experimental staphylococcus osteomyelitis. Proc Soc Exp Biol Med (1977) 1.16
Treatment of patients with pseudomonas endocarditis with high dose aminoglycoside and carbenicillin therapy. Medicine (Baltimore) (1978) 1.16
Randomised, controlled trial of the comparative efficacy, auditory toxicity, and nephrotoxicity of tobramycin and netilmicin. Lancet (1983) 1.14
Hemophilus influenzae bronchopneumonia in adults. Arch Intern Med (1968) 1.14
Idoxuridine in herpes simplex virus (type 1) encephalitis. Experience with 29 cases in Michigan, 1966 to 1971. Ann Intern Med (1973) 1.12
A decade's experience with an individualized clomiphene treatment regimen including its effect on the postcoital test. Fertil Steril (1982) 1.11
An experimental approach to virus myocarditis. Prog Med Virol (1965) 1.09
A new continuing fatigue syndrome following mild viral illness. A proscription to exercise. Chest (1988) 1.08
Microbiologic assays and neurological toxicity during use of adenine arabinoside in humans. J Infect Dis (1976) 1.07
Theophylline-induced seizures: clinical and pathophysiologic aspects. West J Med (1983) 1.05
Modified polyriboinosinic-polyribocytidylic acid complex: sustained interferonemia and its physiological associates in humans. Infect Immun (1979) 1.05
Comparison of the effects of arabinosyladenine, arabinosylhypoxanthine, and arabinosyladenine 5'-monophosphate against herpes simplex virus, varicella-zoster virus, and cytomegalovirus with their effects on cellular deoxyribonucleic acid synthesis. Antimicrob Agents Chemother (1981) 1.04
Mycotic aneurysm and endocarditis. Two uncommon complications of salmonella infection in the same patient. Am J Cardiol (1966) 1.04
The classic bacterial pneumonias. Dis Mon (1975) 1.03
Complement-requiring neutralizing antibodies in Herpesvirus hominis encephalitis. J Immunol (1970) 1.02
Enterovirus hemagglutination: inhibition by several enzymes and sugars. J Immunol (1965) 1.02
A mouse model of dilated-type cardiomyopathy due to coxsackievirus B3. J Infect Dis (1981) 1.01
Synergy of 9-beta-D-arabinofuranosyladenine and human interferon against Herpes simplex virus, type 1. J Infect Dis (1974) 1.00
Herpesvirus hominis encephalitis. Neurological manifestations and use of idoxuridine. Arch Neurol (1970) 1.00
Serologic responses to herpes simplex virus in rabbits: complement-requiring neutralizing, conventional neutralizing, and passive hemagglutinating antibodies. J Infect Dis (1974) 0.99
Virus myopericarditis. Ann Intern Med (1968) 0.99
Pseudomonas cepacia peritonitis associated with contamination of automatic peritoneal dialysis machines. Ann Intern Med (1982) 0.98
Non-traumatic gram-negative bacillary meningitis in the Detroit Medical Center, 1964-1974; (with special mention of cases due to Escherichia coli). Medicine (Baltimore) (1978) 0.97
Synergy between carbenicillin and an aminoglycoside (gentamicin or tobramycin) against Pseudomonas aeruginosa isolated from patients with endocarditis and sensitivity of isolates to normal human serum. J Infect Dis (1979) 0.97
Gentamicin in treatment of primary Gram-negative pneumonias. Am J Med Sci (1970) 0.96
Age-dependent pathogenicity of group B coxsackieviruses in Swiss-Webster mice: infectivity for myocardium and pancreas. J Infect Dis (1980) 0.96
Cellular interactions of several enteroviruses and a reovirus after treatment with sodium borohydride or carbohydrases. Virology (1968) 0.96
Some previously unrecognized features of herpes simplex virus encephalitis. Neurology (1978) 0.94
Characteristics and sequelae of paregoric abuse. Ann Intern Med (1966) 0.93
Enterovirus hemagglutination: inhibition by aldoses and a possible mechanism. J Immunol (1966) 0.92
Antiherpesvirus activity in human sera and urines after administration of adenine arabinoside: in vitro and in vivo synergy of adenine arabinoside and arabinosylhypoxanthine in combination. J Clin Invest (1978) 0.92
Granulocytopenia associated with carbenicillin. Five episodes in two patients. Am J Med (1973) 0.90
Renal and auditory toxicity of high-dose, prolonged therapy with gentamicin and tobramycin in pseudomonas endocarditis. J Infect Dis (1984) 0.90
Agranulocytosis associated with chronic oral administration of cloxacillin for suppression of staphylococcal osteomyelitis. Am J Hematol (1982) 0.90
Role of bacterial infection in exacerbation of multiple sclerosis. Am J Phys Med Rehabil (1996) 0.89
Congenital infections with reovirus. J Exp Med (1966) 0.89
Gram-negative pneumonia in hospitalized patients. Postgrad Med (1975) 0.89
Immunoassay with cytomegalovirus early antigens from gene products p52 and CM2 (UL44 and UL57) detects active infection in patients with chronic fatigue syndrome. J Clin Pathol (2007) 0.89
Pseudomonas endocarditis: hemagglutinating antibodies to Fisher-Devlin-Gnabasik immunotypes in sera. J Lab Clin Med (1974) 0.89
Antiviral activity of an adenosine deaminase inhibitor: decreased replication of herpes simplex virus. J Infect Dis (1975) 0.89
The gram-negative bacillary pneumonias. Dis Mon (1980) 0.88
Pyrogenic reactions after inadvertent infusion of endotoxin during cardiac catheterizations. Ann Intern Med (1980) 0.87
Eczema herpeticum: presenting as hand, foot and mouth syndrome. Mich Med (1972) 0.87
Coxsackievirus B4 myocarditis in mice: valvular changes in virus-infected and control animals. J Infect Dis (1978) 0.86
Guide to immunization against mumps. J Infect Dis (1970) 0.86
Effect of periodate oxidation on hemagglutinating and antibody-producing capacities of certain enteroviruses and reoviruses. Proc Natl Acad Sci U S A (1966) 0.86
Gram-negative bacillary pneumonia. J Infect Dis (1971) 0.86
Studies of in vitro synergy between several beta-lactam and aminoglycoside antibiotics against endocarditis strains of Pseudomonas aeruginosa. J Infect (1984) 0.86
A mouse model of transmural myocardial necrosis due to coxsackievirus B4: observations over 12 months. Intervirology (1982) 0.86
Ventricular aneurysms complicating coxsackievirus group B, types 1 and 4 murine myocarditis. Circulation (1979) 0.85
Gentamicin/amikacin-resistant gram-negative bacilli at Detroit General Hospital, 1975-1976. Am J Med (1977) 0.85
Epidemiologic studies on influenza in familial and general population groups, 1951-1956. V. Effectiveness of adjuvant vaccines. Am J Epidemiol (1969) 0.84
Possible pseudoresistance of Streptococcus pneumoniae to penicillin G in a patient with a mixed pneumococcus-Staphylococcus aureus pneumonia. Am J Med Sci (1984) 0.84
Interferon in biopsy and autopsy specimens of brain. Its presence in herpes simplex virus encephalitis. Arch Neurol (1980) 0.83
Interferon and neutralizing antibody in sera of exercised mice with coxsackievirus B-3 myocarditis. Proc Soc Exp Biol Med (1976) 0.83
Diminution in the size of the thymus in mice during forced swimming. J Infect Dis (1981) 0.83
Herpetic whitlow: a manifestation of primary infection with herpes simplex virus type 1 or type 2. J Infect Dis (1978) 0.83
Ultrasound imaging of residual limbs: new use for an old technique. Arch Phys Med Rehabil (1989) 0.82
Differentiation of several isolates of Peptococcus magnus by counterimmunoelectrophoresis. Infect Immun (1977) 0.82
Assessment of cytosine arabinoside as an antiviral agent in humans. Antimicrob Agents Chemother (1974) 0.82
Modified polyriboinosinic-polyribocytidylic acid complex: induction of serum interferon, fever, and hypotension in rabbits. Antimicrob Agents Chemother (1980) 0.82
Inhibitory and lethal concentrations of 9-beta-D-arabinofuranosyladenine and its hypoxanthine-derivative versus herpes simplex virus, type 1. J Lab Clin Med (1977) 0.82
Concentrations of idoxuridine in serum, urine, and cerebrospinal fluid of patients with suspected diagnoses of Herpesvirus hominis encephalitis. J Clin Invest (1972) 0.82
Synthesis and structure-activity relationships in a series of antiinflammatory corticosteroid analogues, halomethyl androstane-17 beta-carbothioates and -17 beta-carboselenoates. J Med Chem (1994) 0.82
A small, randomized, placebo-controlled trial of the use of antiviral therapy for patients with chronic fatigue syndrome. Clin Infect Dis (2001) 0.81
An estimate of the course of herpes simplex virus encephalitis. Scand J Infect Dis (1976) 0.81
Epidemiologic aspects of postoperative sepsis in a urologic practice (with a note concerning antibacterial prophylaxis). J Urol (1971) 0.81
Characteristics of pneumonias caused by Bacillus proteus. Ann Intern Med (1968) 0.80
Absence of idoxuridine and persistence of herpes simplex virus in brains of patients being treated for encephalitis. Proc Soc Exp Biol Med (1975) 0.80